Legumain-targeted RR-11a-coupled nanoparticles reveal high ligand-receptor affinity,RR-11a enhance solid-tumor penetration and uptake by tumor cells.

Tumor-bearing mice treated with RR-11a-coupled NPs encapsulating doxorubicin results in improved tumor selectivity and drug sensitivity, It completely inhibits tumor growth.